Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing granulocytopenia in sarcoma patients receiving doxorubicin combined with ifosfamide: A prospective, randomized, non-inferiority phase II study.

被引：0
|
作者：
Fan, Li
Ye, Ting
Wang, Zhongliang
Cao, Rubo
Wang, Bicheng
Peng, Ling
Chen, Jing
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Canc Ctr, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Whhan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24173
引用
收藏
页数：1
相关论文
共 31 条
  • [1] Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients
    Yantao Jiang
    Ju Zhang
    Jianxin Zhong
    Hao Liao
    Jiayang Zhang
    Yaxin Liu
    Yuehua Liang
    Huiping Li
    BMC Cancer, 23
  • [2] Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients
    Jiang, Yantao
    Zhang, Ju
    Zhong, Jianxin
    Liao, Hao
    Zhang, Jiayang
    Liu, Yaxin
    Liang, Yuehua
    Li, Huiping
    BMC CANCER, 2023, 23 (01)
  • [3] Advantages of prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: An open-label, randomized, multicenter phase III study
    Xie, Jie
    Cao, Jun
    Wang, Zhonghua
    Wang, Biyun
    Zhang, Sheng
    Wang, Leiping
    Zhang, Jian
    Tao, Zhonghua
    Li, Ting
    Zhang, JinFeng
    Hu, Xi-Chun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study
    Xie, Jie
    Cao, Jun
    Wang, Jing-fen
    Zhang, Bai-hong
    Zeng, Xiao-hua
    Zheng, Hong
    Zhang, Yang
    Cai, Li
    Wu, Yu-dong
    Yao, Qiang
    Zhao, Xiao-chun
    Mao, Wei-dong
    Jiang, Ai-Mei
    Chen, Shao-shui
    Yang, Shun-e
    Wang, Shu-sen
    Wang, Jian-hong
    Pan, Yue-yin
    Ren, Bi-yong
    Chen, Yan-ju
    Ouyang, Li-zhi
    Lei, Kai-jian
    Gao, Jing-hua
    Huang, Wen-he
    Huang, Zhan
    Shou, Tao
    He, Yan-ling
    Cheng, Jing
    Sun, Yang
    Li, Wei-ming
    Cui, Shu-de
    Wang, Xin
    Rao, Zhi-guo
    Ma, Hu
    Liu, Wei
    Wu, Xue-yong
    Shen, Wei-xi
    Cao, Fei-lin
    Xiao, Ze-min
    Wu, Biao
    Tian, Shu-yan
    Meng, Dong
    Shen, Peng
    Wang, Bi-yun
    Wang, Zhonghua
    Zhang, Jian
    Wang, Leiping
    Hu, Xi-chun
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 389 - 399
  • [5] Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study
    Jie Xie
    Jun Cao
    Jing-fen Wang
    Bai-hong Zhang
    Xiao-hua Zeng
    Hong Zheng
    Yang Zhang
    Li Cai
    Yu-dong Wu
    Qiang Yao
    Xiao-chun Zhao
    Wei-dong Mao
    Ai-Mei Jiang
    Shao-shui Chen
    Shun-e Yang
    Shu-sen Wang
    Jian-hong Wang
    Yue-yin Pan
    Bi-yong Ren
    Yan-ju Chen
    Li-zhi Ouyang
    Kai-jian Lei
    Jing-hua Gao
    Wen-he Huang
    Zhan Huang
    Tao Shou
    Yan-ling He
    Jing Cheng
    Yang Sun
    Wei-ming Li
    Shu-de Cui
    Xin Wang
    Zhi-guo Rao
    Hu Ma
    Wei Liu
    Xue-yong Wu
    Wei-xi Shen
    Fei-lin Cao
    Ze-min Xiao
    Biao Wu
    Shu-yan Tian
    Dong Meng
    Peng Shen
    Bi-yun Wang
    Zhonghua Wang
    Jian Zhang
    Leiping Wang
    Xi-chun Hu
    Breast Cancer Research and Treatment, 2018, 168 : 389 - 399
  • [6] Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer
    Li, Weiwei
    Dong, Mohan
    Huang, Shigao
    Shi, Liu
    Yang, Hua
    Zhang, Ying
    Gong, Jie
    Shi, Mei
    Wei, Lichun
    Zhao, Lina
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (02): : 310 - 316
  • [7] Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study
    Huang, Junting
    Zhu, Jia
    Jiang, Lian
    Xu, Jiaqian
    Lin, Xiheng
    Chang, Jian
    Zhang, Xiaohong
    Lu, Suying
    Sun, Feifei
    Wang, Juan
    Que, Yi
    Ye, Zhonglv
    Yang, Lihua
    Yuan, Xiuli
    Cai, Weisong
    Tian, Chuan
    Wu, Yanpeng
    He, Xiangling
    Tang, Yan-Lai
    Zhang, Yizhuo
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [8] PEG-rhG-CSF for prophylaxis of neutropenia after chemotherapy in patients with non-small cell lung cancer: A multicenter, prospective, randomized study
    Sun, Xu-Sheng
    Wang, Zhe
    Ren, Shu-Hua
    Zhang, He-Lin
    Liu, Li-Jun
    Du, Hong-Bo
    Liu, Xiao-Wei
    Liu, Jun-Feng
    THORACIC CANCER, 2022, 13 (17) : 2429 - 2435
  • [9] A Randomized Controlled Clinical Study of Peg-Rhg-CSF for Preventing Chemotherapy-Induced Neutropenia in Patients with B-Cell Non-Hodgkin Lymphoma
    Zhen, Changqing
    Ding, Mei
    Lu, Kang
    Ge, Xueling
    Chen, Na
    Fang, Xiaosheng
    Sui, Xiaohui
    Jiang Yujie
    Liu, Xin
    Li, Ying
    Wang, Xianghua
    Li, Ying
    Zhang, Lingyan
    Xu, Hongzhi
    Fan, Juan
    Wang, Xin
    BLOOD, 2019, 134
  • [10] Safety and efficacy of PEG-rhG-CSF as primary prophylaxis against neutropenia induced by combination chemotherapy regimens involving oral chemotherapy agents in gastrointestinal cancer patients: A prospective, exploratory, non-randomized controlled study.
    Zhao, Jun
    Wang, Hui
    Zhang, Gehong
    Zhang, Xiaoling
    Du, Yunyi
    Ma, Ning
    Yang, Wei
    Yang, Bo
    Gao, Yangjun
    Wang, Mei
    Cai, Linlin
    Feng, Tingting
    Zhang, Na
    Yang, Suxia
    Guo, Xiaobo
    Wang, Ouxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
1234